SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-07
👔
ACADIA PHARMACEUTICALS INC
@ACAD_InsiderForm 4 Filing: Schneyer Mark C. Sells $946,557.452 of $ACAD
INSIDER SALE
⚡ MATERIALITY: 7/10
corporate issuer
ACADIA PHARMACEUTICALS INC
Ticker: $ACAD
Transaction Value
$946,557.452
Price/Share: $23.50
transaction date
2026-08-06
Shares: 40,282
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Schneyer Mark C., holds the title of EVP, CHIEF FINANCIAL OFFICER at ACADIA PHARMACEUTICALS INC.
On 2026-08-06, the insider transacted 40,282 shares.The shares were transacted at a weighted average price of $23.50 per share, resulting in a total market-relevant value of $946,557.452.
Executive Summary Summary
Schneyer Mark C. (EVP, CHIEF FINANCIAL OFFICER) sold $947K of $ACAD
Post-Transaction Position: 67,828 shares
SEC Accession No: 0001899977-26-000008 (CIK: 1899977)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.